Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Production method and application of oat embryo extract

A production method and embryonic technology, applied in the fields of food and cosmetics, pharmaceuticals, and pharmaceuticals, can solve problems such as allergies, bacterial contamination, immune rejection, etc., and achieve the effects of prolonging life and convenient use of medicines

Inactive Publication Date: 2017-05-24
沈会强 +3
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

); In 1998, American scientists succeeded in culturing human embryonic stem cells in vitro. Since then, scholars at home and abroad have used different stem cells to treat different diseases. Both heterogeneous (sheep) and heterogeneous have serious complications such as immune rejection, allergy, and systemic infection caused by contaminated bacteria during in vitro culture.
[0009] Since then, scholars at home and abroad have used different stem cells to treat different diseases, and the short-term therapeutic effect can be confirmed. However, there are currently the following problems: whether it is sheep placenta or human embryonic stem cells, because they are heterogeneous (sheep) and heterogeneous cells, patients will not be able to use them after using them. There are serious complications such as immune rejection, allergy, and systemic infection caused by contaminated bacteria during in vitro culture.
Studies on the application of stem cells in clinical trials have proved that animal stem cells can differentiate into tissue cells, and animal stem cells can repair damaged tissues. However, there is a huge difference between plant stem cells and animal stem cells. Plant stem cells can only differentiate into other types of plant cells, which is absolutely impossible. differentiated human cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Production method and application of oat embryo extract
  • Production method and application of oat embryo extract
  • Production method and application of oat embryo extract

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] The present embodiment provides a kind of preparation method of oat embryonic element

[0039] 1. Obtaining Oat Embryo Tissue

[0040] 1.1 Selected wheat varieties:

[0041] Requirements for selecting rice seeds: preferably from high-yielding, healthy and disease-free rice seeds of the current year. In this example, a high-quality, high-yielding, disease-resistant hybrid oat combination (variety) was obtained from the oat seed base in Wuchuan County, Inner Mongolia, China. According to different production requirements, the number of rice species varies, and 10, 100, 500 kg can be used as a base, and 500 kg of oats can be used as a base according to the test and experimental dosage.

[0042] 1.2 Proper breeding of seedlings:

[0043] Dry the seeds 8 days before sowing, soak them in 1% lime water for 2 to 3 days after drying for 1 to 2 days, to facilitate disinfection and germination, and promote seed germination. Then wash with clean water and soak in cold water for...

Embodiment 2

[0222] OEF Therapeutic Animal Experiments

[0223] Using large and small white mice, rabbits, dogs, and monkeys to make models of different wounds and 15 different diseases, more than 500 different animal experiments were treated successively with control and REF interventions. The models include the following 9 representative diseases of each system: (1) Canine craniocerebral injury model; (2) monkey cerebral ischemia model; (3) canine chronic obstructive pulmonary disease model; (4) canine gastric and duodenal ulcer model; (5) canine liver cirrhosis (cirrhosis) Model; (6) canine acute myocardial infarction; (7) canine diabetes model; (8) canine renal failure model; (9) canine burn model (REF treatment of animal experiments is an innovation of the present invention); (10) other models . Animal model standards in each group are unified according to experimental requirements; curative effect standards are in accordance with relevant disease curative effect standards. This stu...

Embodiment 3

[0229] Clinical Application Trial of OEF

[0230] 1. Diseases treated by OEF:

[0231] Embryotherapy is suitable for diseases of various systems, including sub-health, promoting normal growth and development of children, immune system deficiency diseases, infectious diseases, tumors (various benign and malignant tumors), nervous system diseases, respiratory system diseases, digestive system diseases, Cardiovascular system diseases, endocrine system diseases, skeletal and muscular system diseases, blood system diseases, urinary system diseases, reproductive system diseases, sexual function diseases, peripheral vascular diseases, skin diseases, difficult diseases of eyes, ears, nose, pharynx and larynx , anti-aging and beauty, etc.

[0232] 2. Number of diseases treated by OEF:

[0233] Various diseases and anti-aging treatment methods have treated more than 2,000 patients.

[0234] 3. Treatment options for OEF:

[0235] ①Selection of OEF: Choose OEF products in different do...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a production method of oat embryo extract, which comprises the following processes of: carrying out cell wall-breaking processing on oat embryonic stem cells; roguing; and after centrifugation, obtaining the oat pluripotent embryo extract. The invention further discloses oat embryo extract obtained by adopting the production method and application thereof. According to the invention, the oat pluripotent embryo extract separated from the oat pluripotent embryonic stem cells can realize the effects of human embryo extract, i.e., various cells in a human body can be kept alive and service lives of working cells are prolonged; injured cells are repaired, and functions of the cells are recovered; resting cells in the body are activated, and the effective working cells are supplemented; decay of stem cells of the human body is protected and generation of the stem cells is promoted; resting stem cells of the human body are activated to differentiate new cells to replace dead cells so as to reach an effect of recovering visceral organs.

Description

technical field [0001] The invention relates to the technical fields of pharmaceuticals, food and cosmetics, in particular to an oat embryonic element, and specifically relates to a preparation method and application of the oat embryonic element. Background technique [0002] Although there are thousands of human diseases, there is only one real disease, which is cell disease. If there is a problem with the cell metabolism of any organ, and the cell death reaches a certain level, then this organ will get sick, which is the main cause of cell failure. There are two aspects: one is the lack of cell nutrition and oxygen supply, and the other is that the metabolic waste cannot be discharged in time, which leads to cell poisoning. Now the understanding of the disease is only the manifestation of the disease, not the real cause, and the treatment is mostly symptomatic. (such as the treatment of pain, fever, etc.) or allopathic treatment (resection of tumors, radiotherapy, chemothe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/899A61P1/04A61P1/16A61P3/10A61P9/00A61P9/10A61P13/12A61K8/9794A61Q19/08A61Q19/00
CPCA61K36/899A61K8/97A61K2800/805A61Q19/00A61Q19/08
Inventor 沈会强谢培增刘江郑晓云谢成沈明阳
Owner 沈会强
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products